IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Matricaria chamomilla extract inhibits the metastatic potential of colorectal cancer cell line via reduction of matrix metalloproteinase enzymes activity

Author: HASSAN ABIDI, NAZANIN DANAEI, REZA MAHMOUDI, AREZOO SABET, MANSORE ESMAEILI, MOHSEN NIKSERESHT
Abstract: Background and objective: Chamomile (Matricaria chamomilla) is a medicinal herb containing antioxidant compounds whose effects have been observed in treatment of several diseases. In present study the anti-angiogenic effect of hydro-alcoholic extract of chamomile has been studied in human colorectal cancer HT-29 cell line. Method and material: HT-29 cells were cultured in RPMI1640 media. The cells were exposed to different concentrations of different concentrations of hydro-alcoholic extract of chamomile, bevacizumab and both agents combined. Viability was evaluated by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay (MTT). Vascular endothelial growth factor (VEGF) gene expression and the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9 enzymes were assessed in the presence of this extract. Then data were analyzed using SPSS 21 software, through descriptive and inferential statistics at a 95% confidence level. Also, for drawing the graphs we used GraphPad Prism Version 7. In this study, ethical considerations were respected. Results: The expression of VEGF gene and secretion of VEGF significantly down-regulated in the treated cells group compared to control group (p<0.05). Secretion of VEGF was significantly reduced in cells treated with bevacizumab and the extract synergistically (p<0.05). The activity of MMP-2 and MMP-9 enzymes decreased in the treated cells (p<0.05). Conclusion: Hydro-alcoholic extract of chamomile can affect metastatic potential of colorectal cells via affecting on MMPs activity and VEGF gene expression.
Keyword: Chamomile, Angiogenesis Inhibitors, Bevacizumab, MMP-2, MMP-9, Colorectal Neoplasms, HT29 Cells
DOI: https://doi.org/10.31838/ijpr/2020.12.04.002
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free